Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Catherine, Delbaldo"'
Autor:
Dominique Berton, Anne Floquet, Willy Lescaut, Gabriel Baron, Marie-Christine Kaminsky, Philippe Toussaint, Rémy Largillier, Aude-Marie Savoye, Jérôme Alexandre, Catherine Delbaldo, Emmanuelle Malaurie, Hugues Barletta, Claire Bosacki, Claire Garnier-Tixidre, Philippe Follana, Hortense Laharie-Mineur, Charles Briac Levache, Bruno Valenza, Agnès Dechartres, Delphine Mollon-Grange, Frédéric Selle
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Introduction: Bevacizumab-containing therapy is considered a standard-of-care front-line option for stage IIIB–IV ovarian cancer based on results of randomized phase 3 trials. The multicenter non-interventional ENCOURAGE prospective cohort study as
Externí odkaz:
https://doaj.org/article/759e5d59f76b40d9ba13a0b2c9ebd372
Autor:
E. Malaurie, Claire Bosacki, Aude-Marie Savoye, Claire Garnier-Tixidre, Philippe Toussaint, Agnès Dechartres, Rémy Largillier, Gabriel Baron, Marie-Christine Kaminsky, Dominique Berton, Bruno Valenza, Willy Lescaut, Hortense Laharie-Mineur, Jérôme Alexandre, Anne Floquet, Frédéric Selle, Charles Briac Levache, Hugues Barletta, Philippe Follana, Delphine Mollon-Grange, Catherine Delbaldo
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Frontiers, 2021, 12, ⟨10.3389/fphar.2021.711813⟩
Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacology, Frontiers, 2021, 12, ⟨10.3389/fphar.2021.711813⟩
Frontiers in Pharmacology, Vol 12 (2021)
Introduction: Bevacizumab-containing therapy is considered a standard-of-care front-line option for stage IIIB–IV ovarian cancer based on results of randomized phase 3 trials. The multicenter non-interventional ENCOURAGE prospective cohort study as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cf7a8cd1710e52fe5eebb4d3d33d65f
https://pubmed.ncbi.nlm.nih.gov/34616296
https://pubmed.ncbi.nlm.nih.gov/34616296
Autor:
Gaetan Des Guetz, Thomas Aparicio, Denis Smith, Bruno Valenza, Nathalie Baize, Côme Lepage, Catherine Delbaldo, Denis Père Verge, Olivier Romano, Frédéric Pamoukdjian, Emmanuelle Norguet Monnereau, Anthony Dohan, Claire Falandry, L. Cany, Ariane Darut-Jouve, Christine Le Foll, Pascal Artru, Yves Rinaldi, Carole Monterymard, E. Maillard, Meher Ben Abdelghani, Faiza Khemissa Akouz
Publikováno v:
Journal of geriatric oncology
Journal of geriatric oncology, 2020, ⟨10.1016/j.jgo.2020.04.001⟩
Journal of geriatric oncology, 2020, ⟨10.1016/j.jgo.2020.04.001⟩
International audience; BACKGROUND: Regorafenib significantly increases overall survival (OS) in patients with metastatic colorectal cancer previously treated but gives toxicities. OBJECTIVES: to assess the efficacy and safety of regorafenib at it's
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70d0f66c5746d545c9e0942db5e835dd
https://hal.archives-ouvertes.fr/hal-02901884
https://hal.archives-ouvertes.fr/hal-02901884
Autor:
Frederique Penault-Llorca, Florence Dalenc, Sylvie Chabaud, Paul Cottu, Djelila Allouache, David Cameron, Jean-Philippe Jacquin, Julien Grenier, Laurence Venat Bouvet, Apurna Jegannathen, Mario Campone, Francesco Del Piano, Marc Debled, Anne-Claire Hardy-Bessard, Sylvie Giacchetti, Philippe Barthelemy, Laure Kaluzinski, Audrey Mailliez, Marie-Ange Mouret-Reynier, Eric Legouffe, Anne Cayre, Mathilde Martinez, Catherine Delbaldo, Delphine Mollon-Grange, E. Jane Macaskill, Matthew Sephton, Laëtitia Stefani, Blaha Belgadi, Matthew Winter, Hubert Orfeuvre, Magali Lacroix-Triki, Herve Bonnefoi, Judith Bliss, Jean-Luc Canon, Jerome Lemonnier, Fabrice Andre, Thomas Bachelot
Publikováno v:
Cancer Research. 82:PD9-08
Background: The double blind randomized UNIRAD trial (NCT01805271) showed no evidence that adding Everolimus (EVE) to adjuvant endocrine therapy (EHT) for high-risk early breast cancer (BC) improved 3-year disease-free survival (iDFS) compared with E
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ed0754b8bfa76a813a242ae63bb3ac4
https://doi.org/10.1158/1538-7445.sabcs21-pd9-08
https://doi.org/10.1158/1538-7445.sabcs21-pd9-08
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 4 (2012)
Based on preclinical data available in the RIP1-Tag2 transgenic mouse model, sunitinib is an inhibitor of angiogenesis in pancreatic neuroendocrine tumors blocking vascular endothelial growth factor receptors and platelet-derived growth factor recept
Externí odkaz:
https://doaj.org/article/91337c796cdc4fb5b8e068d8bcb811ed
Autor:
Isabelle Vincent-Cantini, Catherine Barbe, Catherine Delbaldo, Katia Lièvremont, Nathanael Loric, Eléa Duval, Mireille Favier, Vincent Launay, Eric-Alban Giroux, Isabelle Bonnet, Fabienne Le Goc-Sager
Publikováno v:
Bulletin du Cancer. 105:862-872
Resume Introduction De nouvelles formes galeniques de trastuzumab et rituximab ont ete developpees pour administration par voie sous-cutanee, permettant ainsi des protocoles d’administration moins contraignants en hopital de jour. L’objectif de c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b3cef935b01df540ed72d36efe49583
https://doi.org/10.1016/j.bulcan.2018.07.014
https://doi.org/10.1016/j.bulcan.2018.07.014
Autor:
Caroline Cheneau, Suzette Delaloge, Sandrine Marques, Catherine Delbaldo, L. Moreau, François-Clément Bidard, Thomas Bachelot, Jérôme Lemonnier, Thibault De La Motte Rouge, Anne-Claire Hardy-Bessard, Claire Garnier Tixidre, Barbara Pistilli, Frédérique Berger, Nathalie Marques, Florence Dalenc, Olfa Derbel
Publikováno v:
Journal of Clinical Oncology. 39:1070-1070
1070 Background: In PADA-1 (NCT03079011), a phase III trial testing the clinical utility of ESR1mut detection, ER+ HER2- advanced breast patients (ABC pts) received Aromatase Inhibitor (AI) and Palbociclib (Pal) +/- LHRH agonist as first line therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26f7be6f189eceb84279a073024f4c44
https://doi.org/10.1200/jco.2021.39.15_suppl.1070
https://doi.org/10.1200/jco.2021.39.15_suppl.1070
Autor:
Sophie Abadie-Lacourtoisie, Claude El Kouri, Alain Zannetti, Catherine Delbaldo, Isabelle Ray-Coquard, J. Cretin, Elsa Kalbacher, Anne Mercier-Blas, Anne-Claire Hardy-Bessard, Dominique Berton-Rigaud, Emmanuel Blot, Anne Lesoin, Florence Joly, Delphine Mollon, Benoit You, Michel Fabbro, Clémence Romeo, Gilles Freyer, Oana Cojocarasu, Magali Provansal
Publikováno v:
Gynecologic oncology. 152(1)
Background Carboplatin and pegylated liposomal doxorubicin combination is a standard regimen in platinum-sensitive recurrent ovarian cancer patients. The pegylated liposomal doxorubicin shortage from 2011 to 2013 urged assessment of the efficacy and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3c42cf5b8fa9c598cf65138aa2aaf19
https://pubmed.ncbi.nlm.nih.gov/30446275
https://pubmed.ncbi.nlm.nih.gov/30446275
Autor:
Mireille, Favier, Fabienne, Le Goc-Sager, Isabelle, Vincent-Cantini, Vincent, Launay, Eric-Alban, Giroux, Katia, Lièvremont, Isabelle, Bonnet, Catherine, Barbe, Eléa, Duval, Nathanael, Loric, Catherine, Delbaldo
Publikováno v:
Bulletin du cancer. 105(10)
New pharmaceutical forms of trastuzumab and rituximab which can be administered by the subcutaneous route have been developed recently. For day hospitalisation units, these can be used in simpler treatment protocols than previous intravenous formulat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4378b19619d3708e49a8a90821d43e2c
https://pubmed.ncbi.nlm.nih.gov/30244982
https://pubmed.ncbi.nlm.nih.gov/30244982
Autor:
L. Zelek, Pascal Piedbois, Daniel Serin, E. Teissier, Marc Buyse, E. Quinaux, Frank Priou, Catherine Delbaldo, M. Mousseau, P. Laplaige, S. Greget, J. F. Berdah, B. Audhuy
Publikováno v:
European Journal of Cancer. 50:23-30
Background Standard adjuvant chemotherapy regimens for patients with node positive (N+) breast cancer consisted of anthracycline followed by taxane. The European Association for Research in Oncology embarked in 2000 on a phase III trial comparing 6 c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ec0b943607589fd333b1cc916d4d95d
https://doi.org/10.1016/j.ejca.2013.09.023
https://doi.org/10.1016/j.ejca.2013.09.023